Pricing Log in Create free account

Denali Therapeutics Inc. (DNLI) vs Zai Lab Limited Unsponsored ADR (ZLAB)

Denali Therapeutics Inc. and Zai Lab Limited Unsponsored ADR are both Biotechnology companies. Denali Therapeutics Inc. is the larger, with a market value of $2.9B against $2.7B — 1.1× the size. Denali Therapeutics Inc. grew revenue faster over the last twelve months: 194.7% against 5.10%. Zai Lab Limited Unsponsored ADR has the higher net margin (−41.9% vs −171.1%) and the higher return on invested capital (−129.3% vs −260.5%). Across the 18 metrics below, Zai Lab Limited Unsponsored ADR leads on 12 and Denali Therapeutics Inc. on 6.

Valuation

Metric DNLI ZLAB Biotechnology median
P/E n/m n/m 8.50
P/S 11.00 5.78 9.71
P/B 3.94 4.28 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA n/m n/m 0.64
EV/Sales 8.64 4.71 9.21
Earnings yield (16.17%) (7.35%) (33.15%)
Free cash flow yield (13.30%) (6.25%) (25.50%)

Profitability

Metric DNLI ZLAB Biotechnology median
Gross margin 99.97% 56.47% 65.16%
Operating margin (181.51%) (58.74%) 0.00%
Net margin (171.06%) (41.86%) 0.00%
Free cash flow margin (146.31%) (36.13%) 0.00%
Return on equity (54.93%) (26.91%) (56.36%)
Return on assets (44.01%) (16.81%) (48.04%)
Return on invested capital (260.54%) (129.34%) 0.00%

Growth

Metric DNLI ZLAB Biotechnology median
Revenue growth (TTM) 194.68% 5.10% 6.02%
EPS growth (last fiscal year) (15.56%) 38.46% 30.26%
Revenue growth, 5-year CAGR 20.67% 56.54% 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric DNLI ZLAB Biotechnology median
Debt to equity 0.01 0.39 0.00
Current ratio 8.37 2.13 4.72
Net debt to EBITDA 1.56 2.66 0.96

Dividend

Metric DNLI ZLAB Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric DNLI ZLAB Biotechnology median
Market cap 2.93b 2.65b 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack